Alzamend Neuro, Inc. SEC filings ALZN
Alzamend Neuro, Inc. has 397 filings in SEC EDGAR's recent list, going back to Jun 22, 2016. Its latest annual report, Form 10-K, was filed on Jul 22, 2026 for the period ended Apr 30, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 10, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (regulation fd disclosure). The company's fiscal year ends on April 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Sep 29, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Material agreement, Listing notice, Unregistered share sale, Bylaw or fiscal year change
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Other events
|
Jul 21, 2026 | Jul 21, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Apr 17, 2026 | Apr 17, 2026 |
| 8-K |
Current report
Listing notice
|
Mar 20, 2026 | Mar 20, 2026 |
| 8-K |
Current report
Material agreement
|
Mar 6, 2026 | Mar 6, 2026 |
| 8-K |
Current report
Other events
|
Nov 18, 2025 | Nov 18, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 14, 2025 | Oct 14, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Oct 9, 2025 | Oct 9, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Sep 25, 2025 | Sep 25, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Aug 1, 2025 | Aug 1, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 23, 2025 | Jul 23, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 9, 2025 | Jul 9, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Apr 25, 2025 | Apr 25, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 3, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 28, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Results of operations
|
Dec 12, 2024 | Dec 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 15, 2024 | Oct 15, 2024 |
| 8-K |
Current report
Material agreement
|
Oct 3, 2024 | Oct 3, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 31, 2024 | Jul 31, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Jul 12, 2024 | Jul 12, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jul 8, 2024 | Jul 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 22, 2024 | May 22, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 15, 2024 | May 15, 2024 |
| 8-K | Current report | May 13, 2024 | May 13, 2024 |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Regulation FD disclosure
|
May 10, 2024 | May 9, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Auditor change
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure
|
May 7, 2024 | May 7, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 1, 2024 | May 1, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Apr 30, 2024 | Apr 30, 2024 |
| 8-K |
Current report
Material agreement, Listing notice, Unregistered share sale
|
Mar 29, 2024 | Mar 29, 2024 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change
|
Mar 22, 2024 | Mar 22, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 7, 2024 | Mar 7, 2024 |
| 8-K |
Current report
Material agreement, Listing notice, Unregistered share sale, Bylaw or fiscal year change
|
Feb 2, 2024 | Feb 2, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 5, 2024 | Jan 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 16, 2023 | Nov 16, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Oct 30, 2023 | Oct 30, 2023 |
| 8-K |
Current report
Listing notice, Shareholder vote results
|
Sep 29, 2023 | Sep 29, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 22, 2023 | Sep 22, 2023 |
| 8-K |
Current report
Material agreement
|
Sep 8, 2023 | Sep 8, 2023 |
| 8-K |
Current report
Other events
|
Aug 16, 2023 | Aug 16, 2023 |
| 8-K |
Current report
Listing notice
|
Aug 7, 2023 | Aug 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 22, 2023 | Jun 22, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Apr 26, 2023 | Apr 26, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 25, 2023 | Apr 25, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 3, 2023 | Apr 3, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 22, 2023 | Mar 22, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Listing notice
|
Feb 3, 2023 | Feb 3, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 20, 2023 | Jan 20, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 16, 2022 | Nov 16, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 31, 2022 | Oct 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 5, 2022 | Oct 5, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 29, 2022 | Sep 29, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 22, 2022 | Sep 22, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Officer or director change
|
Aug 5, 2022 | Aug 5, 2022 |
| 8-K |
Current report
Listing notice
|
Jul 18, 2022 | Jul 18, 2022 |
| 8-K |
Current report
Listing notice
|
Jun 28, 2022 | Jun 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 6, 2022 | Jun 6, 2022 |
| 8-K/A |
Amended current report
Regulation FD disclosure, Other events
|
Apr 20, 2022 | Apr 20, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 18, 2022 | Apr 18, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 17, 2021 | Dec 17, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 30, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 17, 2021 | Aug 17, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 4, 2021 | Aug 4, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 28, 2021 | Jul 28, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 23, 2021 | Jul 23, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 22, 2021 | Jun 17, 2021 |
Showing 71 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ALZN (Nasdaq)
- Fiscal year ends
- April 30
- Incorporated in
- DE
- Headquarters
- Atlanta, GA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1677077
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.